Cargando…

A novel cell-based assay for the evaluation of anti-ras compounds.

In order to identify drugs active against mutated ras oncogenes we have developed an in vitro assay employing two clones of the human fibrosarcoma cell-line, HT1080 which carries an N-ras gene mutated at codon 61. Clone, HT1080scc2, retains the transformed phenotype of the parental line, whilst the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenkins, D. C., Stables, J. N., Wilkinson, J., Topley, P., Holmes, L. S., Linstead, D. J., Rapson, E. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968724/ https://www.ncbi.nlm.nih.gov/pubmed/8217601

Ejemplares similares

Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice.
por: Topley, P., et al.
Publicado: (1993)

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds
por: Cruz-Migoni, Abimael, et al.
Publicado: (2019)

The C-Terminus of H-Ras as a Target for the Covalent Binding of Reactive Compounds Modulating Ras-Dependent Pathways
por: Oeste, Clara L., et al.
Publicado: (2011)

Ras protein abundance correlates with Ras isoform mutation patterns in cancer
por: Hood, Fiona E., et al.
Publicado: (2023)

A Fast, Sensitive and Accurate High Resolution Melting (HRM) Technology-Based Assay to Screen for Common K-ras Mutations
por: Kramer, D., et al.
Publicado: (2009)

Quorum Sensing in Streptococcus mutans Regulates Production of Tryglysin, a Novel RaS-RiPP Antimicrobial Compound
por: Rued, Britta E., et al.
Publicado: (2021)

Novel Allosteric Sites on Ras for Lead Generation
por: Grant, Barry J., et al.
Publicado: (2011)

Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1
por: Wu, Jiansong, et al.
Publicado: (2019)

Noninvasive Imaging of Ras Activity by Monomolecular Biosensor Based on Split-Luciferase Complementary Assay
por: Chen, Liang, et al.
Publicado: (2017)

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
por: Grasselli, J, et al.
Publicado: (2017)

In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
por: Canavaci, Adriana M. C., et al.
Publicado: (2010)

An evaluation of the effects of intensity and duration on outcomes across treatment domains for children with autism spectrum disorder
por: Linstead, E, et al.
Publicado: (2017)

Case of a Wound in the Omentum
por: Stables, J.
Publicado: (1803)

Mr. Stables, on the Influenza
por: Stables, J.
Publicado: (1803)

Design and Synthesis of Some Novel 4-(4-substituted aryl) Semicarbazones as Anticonvulsant Agents
por: Singh, Anita, et al.
Publicado: (2010)

Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds
por: Ritler, Dominic, et al.
Publicado: (2017)

Evaluation of bioluminescence-based assays of anti-malarial drug activity
por: Hasenkamp, Sandra, et al.
Publicado: (2013)

A Panel of High Resolution Melting (HRM) Technology-Based Assays with Direct Sequencing Possibility for Effective Mutation Screening of EGFR and K-ras Genes
por: Heideman, D. A. M., et al.
Publicado: (2009)

Novel Anti-Infective Compounds from Marine Bacteria
por: Rahman, Hafizur, et al.
Publicado: (2010)

Biomimetic on-chip assay reveals the anti-metastatic potential of a novel thienopyrimidine compound in triple-negative breast cancer cell lines
por: Sigdel, Indira, et al.
Publicado: (2023)

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018)

Identification of small molecules as novel anti-adipogenic compounds based on Connectivity Map
por: Zhang, Shuang, et al.
Publicado: (2022)

PGA(1)-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes
por: Anta, B, et al.
Publicado: (2016)

Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing
por: Schmiegel, Wolff, et al.
Publicado: (2017)

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
por: Miller, Mark Steven, et al.
Publicado: (2012)

Evaluating the 0–10 Point Pain Scale on Adolescent Opioid Use in US Emergency Departments
por: Phan, Michael T., et al.
Publicado: (2021)

Discovery of Hit Compounds Targeting the P4 Allosteric Site of K-RAS, Identified through Ensemble-Based Virtual Screening
por: Gomez-Gutierrez, Patricia, et al.
Publicado: (2023)

Evaluation of Assays for Measurement of Serum (Anti)oxidants in Hemodialysis Patients
por: Ruskovska, Tatjana, et al.
Publicado: (2014)

Synthesis and evaluation of novel spiro derivatives for pyrrolopyrimidines as anti-hyperglycemia promising compounds
por: Fatahala, Samar Said, et al.
Publicado: (2018)

Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
por: Hoshi, Hirotaka, et al.
Publicado: (2017)

Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018)

Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling
por: Yelland, Tamas, et al.
Publicado: (2022)

Erratum for Rued et al., “Quorum Sensing in Streptococcus mutans Regulates Production of Tryglysin, a Novel RaS-RiPP Antimicrobial Compound”
por: Rued, Britta E., et al.
Publicado: (2021)

Solid-State Metalloproteins—An Alternative to Immobilisation
por: Rapson, Trevor D.
Publicado: (2016)

RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres
por: Boleij, Annemarie, et al.
Publicado: (2016)

Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds
por: Pallara, Chiara, et al.
Publicado: (2022)

K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)

ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold
por: Posada, Itziar M. D., et al.
Publicado: (2016)

Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
por: Fernández Montes, A., et al.
Publicado: (2022)

Establishing a Cell-Based High-Content Screening Assay for TCM Compounds with Anti-Renal Fibrosis Effects
por: Wang, Xi-ting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cirvrch2uoeennm69ocu1lbkn8